SWK Holdings to Participate in 2020 Colliers Institutional Investor Conference
SWK Holdings Corporation (Nasdaq: SWKH) announced participation in the virtual 2020 Colliers Institutional Investor Conference on September 10, 2020. Chairman and CEO Winston Black will host one-on-one meetings with institutional investors to discuss the company's business strategies, recent achievements, and future milestones. SWK focuses on specialty finance solutions in the healthcare sector, partnering with product marketers to create long-term value while minimizing equity dilution. Additional information is available on their website.
- None.
- None.
DALLAS, Sept. 9, 2020 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH), a life science focused specialty finance company, today announced that its chairman and chief executive officer, Winston Black, will participate in the 2020 Colliers Institutional Investor Conference, taking place virtually on September 10, 2020 from 9 a.m.ET to 5 p.m. ET.
Mr. Black will host virtual one-on-one meetings with investors to discuss SWK Holdings' business and investment strategy, and highlight recent corporate achievements, as well as anticipated milestones. Institutional investors are invited to request meeting times.
For questions and inquiries regarding the conference or to register for a one-on-one meeting, please contact your Colliers Securities sales representative.
About SWK Holdings:
SWK Holdings Corporation is a specialized finance company with a focus on the global healthcare sector. SWK partners with ethical product marketers and royalty holders to provide flexible financing solutions at an attractive cost of capital to create long-term value for both SWK's business partners and its investors. SWK believes its financing structures achieve an optimal partnership for companies, institutions and inventors seeking capital for expansion or capital and estate planning by allowing its partners to monetize future cash flow with minimal dilution to their equity stakes. SWK also owns Enteris Biopharma, whose core Peptelligence™ drug delivery technology creates oral formulations of peptide-based and BCS class II, III, and IV small molecules. With Enteris, SWK has the opportunity to grow its specialty finance business by actively building a wholly-owned portfolio of milestones and royalties through licensing activities. Additional information on the life science finance market is available on the Company's website at www.swkhold.com.
Safe Harbor Statement
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements including words such as "believes," "expects," "anticipates," "intends," "estimates," "plan," "will," "may," "look forward," "intend," "guidance," "future" or similar expressions are forward-looking statements. Because these statements reflect SWK's current views, expectations and beliefs concerning future events, these forward-looking statements involve risks and uncertainties. Investors should note that many factors, as more fully described under the caption "Risk Factors" and elsewhere in SWK's Form 10-K, Form 10-Q and Form 8-K filings with the Securities and Exchange Commission and as otherwise enumerated herein, could affect the Company's future financial results and could cause actual results to differ materially from those expressed in such forward-looking statements. The forward-looking statements in this press release are qualified by these risk factors. These are factors that, individually or in the aggregate, could cause the Company's actual results to differ materially from expected and historical results. You should not place undue reliance on any forward-looking statements, which speak only as of the date they are made. We assume no obligation to publicly update any forward-looking statements, whether as a result of new information, future developments or otherwise.
View original content:http://www.prnewswire.com/news-releases/swk-holdings-to-participate-in-2020-colliers-institutional-investor-conference-301126235.html
SOURCE SWK Holdings Corporation
FAQ
What event is SWK Holdings participating in on September 10, 2020?
Who is the CEO of SWK Holdings?
What will Winston Black discuss at the conference?
What is the focus of SWK Holdings Corporation?
How can institutional investors schedule meetings with SWK Holdings?
